Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Qing Li Peptide.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 123 | 99.63% | Aug 12, 2026 |
| Tirzepatide | 44 | 99.58% | Jun 16, 2026 |
| GHK-Cu | 36 | 99.81% | Aug 24, 2026 |
| BPC-157 | 34 | 98.34% | Sep 8, 2026 |
| Tesamorelin | 23 | 97.06% | Aug 11, 2026 |
| Ipamorelin | 16 | 99.67% | May 26, 2026 |
| TB-500 | 12 | 92.88% | May 5, 2026 |
| Melanotan II | 7 | 99.7% | Mar 12, 2026 |
| PT-141 | 7 | 99.69% | Sep 3, 2026 |
| CJC-1295 DAC | 6 | 98.94% | Oct 2, 2025 |
| Sermorelin | 6 | 99.49% | Sep 3, 2026 |
| CJC-1295 | 6 | 99.39% | May 12, 2026 |
| MOTS-c | 6 | 98.82% | Aug 3, 2026 |
| CJC-1295 No DAC | 6 | 98.69% | Mar 6, 2026 |
| TB-500 Thymosin Beta-4 | 5 | 99.38% | Mar 1, 2026 |
| Cagrilintide | 4 | 99.23% | Mar 5, 2026 |
| Survodutide | 3 | 98.9% | Oct 2, 2025 |
| TB-500 Fragment 17-23 | 1 | 95.7% | May 26, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| BPC-157 | n/a | 99.7% | Lab E | Sep 8, 2026 | verify |
| Sermorelin | n/a | 98% | Lab E | Sep 3, 2026 | verify |
| PT-141 | n/a | 99.7% | Lab E | Sep 3, 2026 | verify |
| BPC-157 | NHS-26014/QL-261108 | 99.6% | Lab G | Aug 27, 2026 | verify |
| GHK-Cu | n/a | 99.7% | Lab G | Aug 24, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 12, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 12, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | Aug 11, 2026 | verify |
| BPC-157 | n/a | 98.9% | Lab E | Aug 4, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 3, 2026 | verify |
| MOTS-c | n/a | 99.2% | Lab E | Aug 3, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 2, 2026 | verify |
| Tesamorelin | TSM101 | 98.6% | Lab E | Jul 22, 2026 | verify |
| MOTS-c | n/a | 98.4% | Lab E | Jul 16, 2026 | verify |
| Retatrutide | 900-10 | 99.9% | Lab E | Jun 30, 2026 | verify |
| Retatrutide | MARCH 6,2026 | 99.9% | Lab E | Jun 23, 2026 | verify |
| BPC-157 | n/a | n/a | Lab E | Jun 23, 2026 | verify |
| GHK-Cu | March 29,2026 | 99.8% | Lab E | Jun 22, 2026 | verify |
| Retatrutide | RT-090225 | 99.7% | Lab G | Jun 16, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab G | Jun 16, 2026 | verify |
| Tesamorelin | TS072270 | 99.6% | Lab G | Jun 16, 2026 | verify |
| Tirzepatide | T072115 | 99.9% | Lab G | Jun 16, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | Jun 7, 2026 | verify |
| Retatrutide | n/a | 99.3% | Lab G | Jun 7, 2026 | verify |
| Tirzepatide | n/a | 99.7% | Lab G | Jun 7, 2026 | verify |
Showing 25 most recent of 345. Search the full database on the CoA page.
Sell or represent Qing Li Peptide? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/qing-li-peptide/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/qing-li-peptide.svg" alt="Qing Li Peptide: lab tested, 345 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.